Ameriprise’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-71,203
| Closed | -$879K | – | 4194 |
|
|
2024
Q4 | $879K | Buy |
71,203
+13,862
| +24% | +$159K | ﹤0.01% | 3301 |
|
|
2024
Q3 | $653K | Buy |
57,341
+2,605
| +5% | +$26.1K | ﹤0.01% | 3388 |
|
|
2024
Q2 | $391K | Sell |
54,736
-8,511
| -13% | -$65.1K | ﹤0.01% | 3503 |
|
|
2024
Q1 | $424K | Sell |
63,247
-26,743
| -30% | -$184K | ﹤0.01% | 3470 |
|
|
2023
Q4 | $585K | Sell |
89,990
-206,973
| -70% | -$1.33M | ﹤0.01% | 3392 |
|
|
2023
Q3 | $2.8M | Sell |
296,963
-26,868
| -8% | -$323K | ﹤0.01% | 2661 |
|
|
2023
Q2 | $4.52M | Sell |
323,831
-11,352
| -3% | -$194K | ﹤0.01% | 2421 |
|
|
2023
Q1 | $6.29M | Sell |
335,183
-6,898
| -2% | -$113K | ﹤0.01% | 2157 |
|
|
2022
Q4 | $4.71M | Sell |
342,081
-8,708
| -2% | -$133K | ﹤0.01% | 2332 |
|
|
2022
Q3 | $6.71M | Sell |
350,789
-251,215
| -42% | -$4.58M | ﹤0.01% | 2005 |
|
|
2022
Q2 | $9.19M | Sell |
602,004
-11,768
| -2% | -$174K | ﹤0.01% | 1813 |
|
|
2022
Q1 | $12.5M | Buy |
613,772
+9,323
| +2% | +$190K | ﹤0.01% | 1723 |
|
|
2021
Q4 | $17.6M | Buy |
604,449
+548,797
| +986% | +$15.7M | ﹤0.01% | 1523 |
|
|
2021
Q3 | $1.2M | Buy |
55,652
+16,981
| +44% | +$410K | ﹤0.01% | 3089 |
|
|
2021
Q2 | $991K | Sell |
38,671
-559
| -1% | -$11.9K | ﹤0.01% | 3230 |
|
|
2021
Q1 | $715K | Buy |
+39,230
| New | +$652K | ﹤0.01% | 3277 |
|
|
2017
Q1 | – | Sell |
-1,913
| Closed | -$4K | – | 3692 |
|
|
2016
Q4 | $4K | Sell |
1,913
-16,520
| -90% | -$38.6K | ﹤0.01% | 3854 |
|
|
2016
Q3 | $55K | Sell |
18,433
-572
| -3% | -$1.54K | ﹤0.01% | 3700 |
|
|
2016
Q2 | $48K | Sell |
19,005
-32,234
| -63% | -$89.8K | ﹤0.01% | 3686 |
|
|
2016
Q1 | $151K | Sell |
51,239
-8,284
| -14% | -$44.3K | ﹤0.01% | 3579 |
|
|
2015
Q4 | $487K | Buy |
+59,523
| New | +$481K | ﹤0.01% | 3276 |
|
|
2015
Q2 | – | Sell |
-1,794
| Closed | -$17K | – | 4078 |
|
|
2015
Q1 | $17K | Buy |
1,794
+260
| +17% | +$2.5K | ﹤0.01% | 3768 |
|
|
2014
Q4 | $15K | Buy |
1,534
+1,434
| +1,434% | +$14.4K | ﹤0.01% | 3670 |
|
|
2014
Q3 | $1K | Buy |
100
+97
| +3,233% | +$1.09K | ﹤0.01% | 5596 |
|
|
2014
Q2 | $0 | Buy |
+3
| New | +$38 | ﹤0.01% | 5672 |
|
|
2013
Q4 | – | Sell |
-1,463
| Closed | -$14K | – | 5442 |
|
|
2013
Q3 | $14K | Buy |
1,463
+242
| +20% | +$2.4K | ﹤0.01% | 4665 |
|
|
2013
Q2 | $11K | Buy |
+1,221
| New | +$12.8K | ﹤0.01% | 4725 |
|
Other funds holding CDMO
Ameriprise's CDMO Position: Q1 2025 in Review
Ameriprise sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q1 2025, closing a stake of 71,203 shares — an estimated $879K sold.
Ameriprise first reported a position in CDMO in Q2 2013 and held it in 27 quarters. The position peaked at $17.6M in Q4 2021. 2 funds tracked by Wall St. Rank hold CDMO as of Q1 2025.
- Ameriprise reported no remaining Avid Bioservices, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
- Ameriprise sold 71,203 Avid Bioservices, Inc. Common Stock shares in Q1 2025, an estimated $879K.
- Ameriprise first reported a position in Avid Bioservices, Inc. Common Stock in Q2 2013 and held it in 27 quarters.
- Ameriprise's Avid Bioservices, Inc. Common Stock position peaked at $17.6M in Q4 2021.
- 2 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q1 2025.
Based on Ameriprise's 13F filing for Q1 2025, filed 14 May 2025.